Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New tech is giving scientists unprecedented insights into single cells’ inner workings.
From immunotherapy to liquid biopsies to new research on side effects—here’s what to expect in 2019.
A look back at some of the major news stories we covered this year.
They are geared to the 10 to 15 percent of people with endometrial cancer who are diagnosed with an advanced stage of the disease.
Pembrolizumab led to 56 percent overall response rate for rare skin cancer.
Long-term remission seen in children with leukemia and adults with lymphoma.
Here are the cancer treatment news stories with the most views this year.
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Cancer world is full of ups and downs.
Tecentriq combo slows progression of hard-to-treat breast cancer.
ORR, PFS, TTP…we help you sort out what they mean.
Checkpoint inhibitor immunotherapy, alone or in combination with chemotherapy, shows promise for advanced non-small-cell lung cancer.
James Allison and Tasuku Honjo win Nobel Prize for immune checkpoint discoveries.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.